Celltrion aims to raise self-injectable Remsima SC market share to 50% in Europe
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
The market share of Remsima SC is expected to grow fast amid the easing of pandemic restrictions as patients prefer self-administration at home to save time and cost from hospital visits for injection on top of its better treatment outcomes, Celltrion Healthcare Marketing Director Choi Byung-seo said on Thursday.
Choi’s comment comes after positive results of a Phase 3 study of Remsima SC presented at the 2022 European Association for Rheumatology (EULAR), with more treatment benefits versus infliximab intravenous (IV) in the treatment of rheumatoid arthritis (RA) patients.
EULAR sets the treatment goal of reaching LDA and remission rate within 30 weeks for RA treatment, which recommends considering a different regimen for patients when the goal is not met.
Remsima SC is expected to be launched in the United States in early 2024. Celltrion is targeting the entire market of anti-TNF-α treatments worth $50 billion for Remsima SC, about five times larger than the Remsima target market. Subcutaneously administered Humira and Enbrel are key rivals in this sector.
Celltrion is also building a direct sales network in the U.S. to improve profitability of its biosimilar products. The ongoing merger of three Celltrion Group companies will bring more flexibility in drug pricing to increase competitiveness, Choi added.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- NPS, Teachers’ Union, Agri Coop invest $266 in SkyLake’s acquisition of TmaxSoft - Pulse by Maeil Business News Korea
- MBK Partners joins race to buy Toshiba - Pulse by Maeil Business News Korea
- SKC shares rally on talk of $1.3 bn sale of PET biz to focus on battery materials - Pulse by Maeil Business News Korea
- Korea’s first app-based lender KBank to stick to IPO plan for the summer - Pulse by Maeil Business News Korea
- Korea’s inflation hits above 5% May and to stay so throughout summer - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- AI가 실시간으로 가격도 바꾼다…아마존·우버 성공 뒤엔 ‘다이내믹 프라이싱’
- 서예지, 12월 29일 데뷔 11년 만에 첫 단독 팬미팅 개최 [공식] - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이